Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial
Titel:
Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial
Auteur:
Cheng, Hongyan Zong, Liju Kong, Yujia Wang, Xiaoyu Gu, Yu Cang, Wei Zhao, Jun Wan, Xirun Yang, Junjun Xiang, Yang